| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Lyell Immunopharma, Inc. | Director | Common Stock | 2.97 M | $6.77 M | $2.28 | Jun 14, 2024 | Direct |
| Lyell Immunopharma, Inc. | Director | Common Stock | 685 K | $1.56 M | $2.28 | Jun 14, 2024 | Grantor |
| Lyell Immunopharma, Inc. | Director | Option (right to buy) | 130 K | Jun 14, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| LYEL | Lyell Immunopharma, Inc. | Jun 14, 2024 | 1 | $0 | 4 | Jun 17, 2024 | Director |
| LYEL | Lyell Immunopharma, Inc. | Sep 8, 2023 | 1 | $0 | 4 | Sep 8, 2023 | Director |
| LYEL | Lyell Immunopharma, Inc. | Aug 15, 2023 | 1 | -$132 K | 4 | Aug 17, 2023 | Director |
| LYEL | Lyell Immunopharma, Inc. | Jun 16, 2023 | 1 | $0 | 4 | Jun 20, 2023 | Director |
| LYEL | Lyell Immunopharma, Inc. | Sep 23, 2022 | 1 | -$71 K | 4 | Sep 27, 2022 | Director |
| LYEL | Lyell Immunopharma, Inc. | Jun 21, 2021 | 2 | $0 | 4 | Jun 23, 2021 | Executive Chairman, Director |
| LYEL | Lyell Immunopharma, Inc. | Jun 16, 2021 | 0 | $0 | 3 | Jun 16, 2021 | Executive Chairman, Director |
| LYEL | Lyell Immunopharma, Inc. | Jun 8, 2021 | 1 | $0 | 4 | Jun 10, 2022 | Director |